Back to Atlas
BSemi-durableNootropic/stimulant caution
CMP-0197
Experimental
GB-115
Anxiolytic / Nootropic
Anxiolytic and cognitive-stability positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Peptide mimetic
- Primary mechanism
- CCK receptor-related anxiolytic peptide mimetic
- Primary market use
- Anxiety/cognition
Pharmacology
- Molecular weight (Da)
- Not established
- Oral bioavailability
- Unknown
- Half-life
- ~5–60 min parent peptide; analogs may be longer
- Route tags
- SubQ; Injectable; route-dependent
- Evidence level
- Research
- Clinical status
- Experimental
- Value-for-money score
- 4 / 10
Reported protocol signal
No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
EveryChem anxiolytic/nootropic listing